Telesis Bio Reports First Quarter 2023 Financial Results

-- Total revenue of $6.3M in 1QFY23 -- BioXp® franchise revenue increased by 28% SAN DIEGO, May 11, 2023 -- Telesis Bio Inc. , a leader in automated multi-omic and synthetic biology... | June 15, 2023

Related Keywords

San Diego ,California ,United States ,Toddr Nelson ,Jen Carroll ,Exchange Commission On ,Telesis Bio Inc ,Gibson Assembly ,Nasdaq ,Bioxp System ,Amplification Kit ,Select Plasmid Amplification Kit ,Conference Call ,Telesis Bio ,Private Securities Litigation Reform Act ,Risk Factors ,Annual Report ,Exchange Commission ,Operations Financial ,Months Ended ,Sheet Data ,